Concourse Financial Group Securities, Inc. Drug Manufacturers—Specialty & Generic

Concourse Financial Group Securities, Inc.

$0
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
AKAN Akanda Corp.	$41.3M	$0 100.0% of portfolio	0	Q1 2025 New
ALKS Alkermes Plc.	$4.36B	$0 100.0% of portfolio	0	Q1 2025 New
TKNO Alpha Teknova, Inc.	$145M	$0 100.0% of portfolio	0	Q1 2025 New
ALVO Alvotech	$2.16B	$0 100.0% of portfolio	0	Q1 2025 New
AMRX Amneal Pharmaceuticals, Inc.	$1.21B	$0 100.0% of portfolio	0	Q1 2025 New
AMPH Amphastar Pharmaceuticals, Inc.	$1.1B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
ANIP Ani Pharmaceuticals Inc	$1.16B	$0 100.0% of portfolio	0	Q1 2025 New
AQST Aquestive Therapeutics, Inc.	$222M	$0 100.0% of portfolio	0	Q1 2025 New
ASRT Assertio Holdings, Inc.	$35.2M	$0 100.0% of portfolio	0	Q1 2025 New
ATNX Athenex, Inc.	$1.57M	$0 100.0% of portfolio	0	Q1 2025 New
AYTU Aytu Biopharma, Inc	$155M	$0 100.0% of portfolio	0	Q1 2025 New
BHC Bausch Health Companies Inc.	$2.45B	$0 100.0% of portfolio	0	Q1 2025 New
CRDL Cardiol Therapeutics Inc.	$87.3M	$0 100.0% of portfolio	0	Q1 2025 New
CPHI China Pharma Holdings, Inc.	$87.8M	$0 100.0% of portfolio	0	Q1 2025 New
COLL Collegium Pharmaceutical, Inc	$1.1B	$0 100.0% of portfolio	0	Q1 2025 New
CRON Cronos Group Inc.	$782M	$0 100.0% of portfolio	0	Q1 2025 New
CPIX Cumberland Pharmaceuticals Inc	$50.6M	$0 100.0% of portfolio	0	Q1 2025 New
RDY Dr Reddys Laboratories LTD	$2.44B	$0 100.0% of portfolio	0	Q1 2025 New
DVAX Dynavax Technologies Corp	$1.41B	$0 100.0% of portfolio	0	Q1 2025 New
ELAN Elanco Animal Health Inc	$6.96B	$0 100.0% of portfolio	0	Q1 2025 New
EMBC Embecta Corp.	$620M	$0 100.0% of portfolio	0	Q1 2025 Sold Out
EBS Emergent Bio Solutions Inc.	$372M	$0 100.0% of portfolio	0	Q1 2025 New
ESPR Esperion Therapeutics, Inc.	$99.2M	$0 100.0% of portfolio	0	Q1 2025 New
EOLS Evolus, Inc.	$541M	$0 100.0% of portfolio	0	Q1 2025 Sold Out
EVO Evotec Se	$1.43B	$0 100.0% of portfolio	0	Q1 2025 New
HLN Haleon PLC	$44.5B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
HROW Harrow Health, Inc.	$1.01B	$0 100.0% of portfolio	0	Q1 2025 New
HCM Hutchmed (China) LTD	$3.08B	$0 100.0% of portfolio	0	Q1 2025 New
INCR Intercure Ltd.	$69.5M	$0 100.0% of portfolio	0	Q1 2025 New
ITCI Intra Cellular Therapies, Inc.	$12.4B	$0 100.0% of portfolio	0	Q1 2025 New
IRWD Ironwood Pharmaceuticals Inc	$126M	$0 100.0% of portfolio	0	Q1 2025 New
DERM Journey Medical Corp	$86.9M	$0 100.0% of portfolio	0	Q1 2025 New
JUPW Jupiter Wellness, Inc.	$64.5M	$0 100.0% of portfolio	0	Q1 2025 New
KMDA Kamada LTD	$349M	$0 100.0% of portfolio	0	Q1 2025 New
LNDC Landec Corp \Ca\	$0	$0 100.0% of portfolio	0	Q1 2025 New
LCI Lannett CO Inc	$1.29M	$0 100.0% of portfolio	0	Q1 2025 New
LNTH Lantheus Holdings, Inc.	$4.88B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
NBIX Neurocrine Biosciences Inc	$12.6B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
ORGO Organogenesis Holdings Inc.	$622M	$0 100.0% of portfolio	0	Q1 2025 New
PCRX Pacira Bio Sciences, Inc.	$1B	$0 100.0% of portfolio	0	Q1 2025 New
PRGO Perrigo CO PLC	$3.78B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
PAHC Phibro Animal Health Corp	$599M	$0 100.0% of portfolio	0	Q1 2025 New
PBH Prestige Consumer Healthcare Inc.	$3.8B	$0 100.0% of portfolio	0	Q1 2025 Sold Out
PRPH Pro Phase Labs, Inc.	$6.73M	$0 100.0% of portfolio	0	Q1 2025 New
RDHL Red Hill Biopharma Ltd.	$141M	$0 100.0% of portfolio	0	Q1 2025 New
RGC Regencell Bioscience Holdings LTD	$198M	$0 100.0% of portfolio	0	Q1 2025 New
RMTI Rockwell Medical, Inc.	$11.5M	$0 100.0% of portfolio	0	Q1 2025 New
SCYX Scynexis Inc	$23.2M	$0 100.0% of portfolio	0	Q1 2025 New
SIGA Siga Technologies Inc	$516M	$0 100.0% of portfolio	0	Q1 2025 New
SSIC Silver Spike Investment Corp.	$0	$0 100.0% of portfolio	0	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.